In short

Lyophilized powder is a material that has had its water removed by freeze-drying (lyophilization): it's frozen, then the ice is removed directly as vapor, skipping the liquid phase entirely. Most research peptides are supplied this way, not as an arbitrary industry convention, but because peptides (short amino-acid chains) are significantly less stable in solution than in dry form.

Catalog and verification

See the research peptide catalog with an open COA (certificate of analysis) for every batch.

How it works

The process has three stages:

  1. Freezing. The peptide solution is frozen quickly to form small ice crystals (this affects the final powder structure).
  2. Primary drying (sublimation). The material is placed under vacuum and gently warmed, the ice converts directly to vapor, bypassing the liquid phase. This is where "freeze-drying" gets its name.
  3. Secondary drying (desorption). Residual unfrozen moisture that was chemically bound to the molecule is removed by raising the temperature further under continued low pressure.

The result is a loose white powder or cake in a vial, sealed under vacuum or an inert gas.

Why it isn't supplied pre-dissolved

The peptide bond and amino-acid side chains are susceptible to hydrolysis, oxidation, and aggregation in an aqueous environment. In solution at room temperature, degradation can occur within days or weeks; lyophilized and properly stored, the same material can remain stable for months to years. That's why the reagent is reconstituted immediately before short-term use in a study rather than kept as a ready solution long-term.

What this means for storage

  • Dry powder is kept in an airtight container, protected from light and moisture, refrigerated (+2…+8 °C) or frozen (-20 °C or below) for long-term storage.
  • Hygroscopicity. Many lyophilizates readily absorb moisture from the air, avoid opening the vial unnecessarily and avoid repeated freeze-thaw cycles, which cause condensation.
  • After reconstitution, stability drops sharply, the solution is typically kept refrigerated and used within a short window, or split into single-use aliquots and frozen.

Why the dry form is more stable: the molecular picture

In a properly executed lyophilization cycle, peptide molecules end up locked into an amorphous, glass-like matrix rather than an ordered crystalline lattice. That amorphous state sharply limits molecular mobility: with no free water and no ability to diffuse relative to one another, peptide chains simply cannot interact the way they would in solution. This is why storage temperature matters so much for shelf life: at +2…+8 °C, residual molecular mobility is higher than at -20 °C, which is why manufacturers typically list a wider acceptable temperature range for short-term storage and a narrower, colder one for long-term storage. This isn't an arbitrary rule, it follows from the physics of the glassy state: the further the storage temperature sits below the material's glass transition temperature, the slower any residual degradation processes run.

Reconstitution: what to watch for

Once a solvent is added (most often bacteriostatic or sterile water for injection, in a lab context), the molecule returns to the same unstable aqueous state that lyophilization was meant to avoid in the first place. That means the stability clock resets the moment the powder is dissolved, and it now counts in days rather than months. Practical rules for handling the reconstituted material in a lab setting: add the solvent slowly down the vial wall rather than directly onto the powder in a stream (a hard jet can denature part of the molecule); don't shake the vial, gently invert or swirl it until the powder dissolves; keep the reconstituted solution refrigerated and use it within a short window, or split it into single-use aliquots and freeze them immediately. For a step-by-step volume and concentration calculation, see the reconstitution guide and the reconstitution calculator.

Frequently asked questions

There's barely any visible powder in the vial, is that normal?

Yes. The peptide mass listed on the label is a dry solid, and for typical research-peptide quantities (micrograms to a few milligrams) its volume is visually tiny, often just a thin film or a few grains at the bottom of the vial. The visible amount of powder says nothing about its mass.

The powder looks slightly yellowed or has compacted into a clump, is that a defect?

A slight color shift or compaction into a compact "cake" isn't by itself a sign of a defect, it's a normal outcome of the lyophilization cycle for some peptides. Genuine warning signs, a sharp color change, visible moisture, or an odor, in that case check the batch against its COA or contact support.

Can lyophilized powder be stored at room temperature?

Briefly (for example, during shipping) most lyophilized peptides tolerate it, which is exactly why the dry form was chosen for logistics in the first place. For planned storage, though, stick to the refrigerator or freezer ranges described above, room temperature accelerates residual degradation even in dry form.

Why are some peptides supplied as powder and others aren't?

Some short, chemically sturdier peptides can be supplied in solution with added preservatives, but for most longer-chain research peptides lyophilization remains the standard, precisely because of the hydrolysis and oxidation sensitivity described above.

Further reading

Not usage instructions

This material is general reference information about the physicochemical properties of lyophilized reagents for laboratory practice. It does not describe dosing or administration schedules for humans. Longeva's products are intended strictly for laboratory research (research use only) and not for use in humans or animals.